Concepedia

Publication | Open Access

Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K/AKT pathway

DOIFull Paper Access

39

Citations

46

References

2020

Year

Yu‐Song Nie, Chengxiao Fu, Huimin Zhang, Min Zhang, Hui Xie, Xiaopei Tong, Yao Li, Zhenyan Hou, Xinrong Fan, Miao Yan
BMC Complementary Medicine and Therapies

Abstract

Celastrol functions as a potential therapeutic substance, acting via the PI3K/AKT pathway to attenuate renal injury, inhibit glomerular basement membrane thickening, and achieve podocyte homeostasis in diabetic nephropathy.

References

YearCitations

Page 1